IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
470,40 € ↓ -12,40 (-2,57%)
2026-06-03
AKTIENPREIS
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership868 shares
Latest Disclosed Value $ 487,721
Alps Advisors Inc reports 20.89% increase in ownership of IX1 / IDEXX Laboratories, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 868 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $423,584 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 718 shares of IDEXX Laboratories, Inc.. This represents a change in shares of 20.89% during the quarter. The current value of the position is $408,307 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F IDEXX LABS COM 45168D104 868 150 20.89 488 0.41 0.0021
2026-02-12 2025-12-31 13F IDEXX LABS COM 45168D104 718 8 1.13 486 7.06 0.0028
2025-11-05 2025-09-30 13F IDEXX LABS COM 45168D104 710 -150 -17.44 454 -1.74 0.0025
2025-08-11 2025-06-30 13F IDEXX LABS COM 45168D104 860 10 1.18 461 29.49 0.0027
2025-04-30 2025-03-31 13F IDEXX LABS COM 45168D104 850 850 357 0.0021
2024-11-12 2024-09-30 13F IDEXX LABS COM 45168D104 0 -631 -100.00 0 -100.00
2024-08-13 2024-06-30 13F IDEXX LABS COM 45168D104 631 -3 -0.47 307 -10.23 0.0021
2024-05-14 2024-03-31 13F IDEXX LABS COM 45168D104 634 -34 -5.09 342 -7.57 0.0024
2024-02-14 2023-12-31 13F IDEXX LABS COM 45168D104 668 -45 -6.31 371 18.97 0.0029
2023-11-14 2023-09-30 13F IDEXX LABS COM 45168D104 713 13 1.86 312 -11.40 0.0026
2023-08-14 2023-06-30 13F IDEXX LABS COM 45168D104 700 10 1.45 352 1.74 0.0031
2023-05-10 2023-03-31 13F IDEXX LABS COM 45168D104 690 690 345 0.0030
2022-11-14 2022-09-30 13F IDEXX LABS COM 45168D104 0 -687 -100.00 0 -100.00
2022-08-15 2022-06-30 13F/A-1 IDEXX LABS COM 45168D104 687 -7 -1.01 241 -36.58 0.0023
2022-08-11 2022-06-30 13F IDEXX LABS COM 45168D104 687 -7 241 0.0023
2022-05-16 2022-03-31 13F IDEXX LABS COM 45168D104 694 138 24.82 380 3.83 0.0041
2022-02-09 2021-12-31 13F IDEXX LABS COM 45168D104 556 7 1.28 366 7.33 0.0041
2021-11-15 2021-09-30 13F IDEXX LABS COM 45168D104 549 -120 -17.94 341 -19.39 0.0033
2021-08-11 2021-06-30 13F IDEXX LABS COM 45168D104 669 0 0.00 423 29.36 0.0037
2021-05-07 2021-03-31 13F IDEXX LABS COM 45168D104 669 -40 -5.64 327 -7.63 0.0032
2021-02-03 2020-12-31 13F IDEXX LABS COM 45168D104 709 -2,431 -77.42 354 -71.31 0.0040
2020-11-05 2020-09-30 13F/A-1 IDEXX LABS COM 45168D104 3,140 -441 -12.31 1,234 4.31 0.0182
2020-11-04 2020-09-30 13F IDEXX LABS COM 45168D104 3,140 -441 1,234 15,815.1884
2020-08-05 2020-06-30 13F IDEXX LABS COM 45168D104 3,581 360 11.18 1,183 51.47 0.0159
2020-05-06 2020-03-31 13F IDEXX LABS COM 45168D104 3,221 -569 -15.01 781 -21.11 0.0121
2020-02-07 2019-12-31 13F IDEXX LABS COM 45168D104 3,790 -156 -3.95 990 -7.74 0.0077
2019-11-04 2019-09-30 13F IDEXX LABS COMMON STOCK 45168D104 3,946 1,196 43.49 1,073 41.74 0.0084
2019-08-07 2019-06-30 13F IDEXX LABS COMMON STOCK 45168D104 2,750 -828 -23.14 757 -5.37 0.0056
2019-05-01 2019-03-31 13F IDEXX LABS COMMON STOCK 45168D104 3,578 -243 -6.36 800 12.52 0.0057
2019-02-04 2018-12-31 13F IDEXX LABS COMMON STOCK 45168D104 3,821 16 0.42 711 -25.16 0.0055
2018-10-25 2018-09-30 13F IDEXX LABS COMMON STOCK 45168D104 3,805 3,805 950 0.0062
2016-05-10 2016-03-31 13F IDEXX LABORATORIES Common Stock 45168D104 0 0 0 0.0000
2016-02-05 2015-12-31 13F IDEXX LABORATORIES Common Stock 45168D104 0 0 0 0.0000
2015-11-13 2015-09-30 13F IDEXX LABORATORIES Common Stock 45168D104 0 -6,964 -100.00 0 -100.00
2015-08-12 2015-06-30 13F IDEXX LABORATORIES Common Stock 45168D104 6,964 3,536 103.15 447 -15.66 0.0038
2015-05-15 2015-03-31 13F IDEXX LABORATORIES Common Stock 45168D104 3,428 -1,614 -32.01 530 -7.99 0.0043
2014-02-11 2013-12-31 13F IDEXX LABORATORIES Common Stock 45168D104 5,042 -266 -5.01 576 8.88 0.0058
2013-11-13 2013-09-30 13F IDEXX LABORATORIES Common Stock 45168D104 5,308 1,472 38.37 529 53.78 0.0059
2013-08-02 2013-06-30 13F IDEXX LABS Common Stock 45168D104 3,836 3,836 344 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.